Biomanufacturing 101 With OmniaBio
From Lab to Line: Building Biomanufacturing Capacity
In this episode, we find out how biomanufacturing is similar to and distinct from other kinds of manufacturing with Mitchel Sivilotti, CEO of OmniaBio.
Mitchel takes us through OmniaBio’s journey from its germination in the Centre for Commercialization of Regenerative Medicine (CCRM) in Toronto to opening a 100,000 square foot facility in Hamilton. We chat about what OmniaBio learned about manufacturing from Toyota, how robotics and AI are influencing patient outcomes, and the value of ecosystem partnerships.
Got a burning question about manufacturing? Submit it to our new ‘Ask Brendan Anything’ segment by DM’ing us on LinkedIn: linkedin.com/company/trilliummfg
Featured Report
- Trillium at 10 Strategy Report
Find Out More about OmniaBio and CCRM